Assertio Holdings Inc
NASDAQ:ASRT
Assertio Holdings Inc
Inventory
Assertio Holdings Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
Inventory
$24.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$14.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$11.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$12.2B
|
CAGR 3-Years
41%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
Assertio Holdings Inc
Glance View
Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.
See Also
What is Assertio Holdings Inc's Inventory?
Inventory
24.8m
USD
Based on the financial report for Sep 30, 2025, Assertio Holdings Inc's Inventory amounts to 24.8m USD.
What is Assertio Holdings Inc's Inventory growth rate?
Inventory CAGR 10Y
8%
Over the last year, the Inventory growth was -38%. The average annual Inventory growth rates for Assertio Holdings Inc have been 20% over the past three years , 13% over the past five years , and 8% over the past ten years .
